Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 8

MIOTIC study: a prospective, multicenter, randomized study to evaluate the long-term efficacy of mobile phone-based Internet of Things in the management of patients with stable COPD

Authors Zhang J, Song Y, Bai C

Received 19 June 2013

Accepted for publication 1 August 2013

Published 19 September 2013 Volume 2013:8 Pages 433—438


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Jing Zhang, Yuan-lin Song, Chun-xue Bai

Department of Pulmonary Medicine, Zhongshan Hospital, Fudan University, Shanghai, People's Republic of China

Abstract: Chronic obstructive pulmonary disease (COPD) is a common disease that leads to huge economic and social burden. Efficient and effective management of stable COPD is essential to improve quality of life and reduce medical expenditure. The Internet of Things (IoT), a recent breakthrough in communication technology, seems promising in improving health care delivery, but its potential strengths in COPD management remain poorly understood. We have developed a mobile phone-based IoT (mIoT) platform and initiated a randomized, multicenter, controlled trial entitled the ‘MIOTIC study’ to investigate the influence of mIoT among stable COPD patients. In the MIOTIC study, at least 600 patients with stable GOLD group C or D COPD and with a history of at least two moderate-to-severe exacerbations within the previous year will be randomly allocated to the control group, which receives routine follow-up, or the intervention group, which receives mIoT management. Endpoints of the study include (1) frequency and severity of acute exacerbation; (2) symptomatic evaluation; (3) pre- and post-bronchodilator forced expiratory volume in 1 second (FEV1) and FEV1/forced vital capacity (FVC) measurement; (4) exercise capacity; and (5) direct medical cost per year. Results from this study should provide direct evidence for the suitability of mIoT in stable COPD patient management.

Keywords: Internet of Things, mobile phone, chronic obstructive pulmonary disease, efficacy

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Other articles by this author:

Expert consensus on acute exacerbation of chronic obstructive pulmonary disease in the People's Republic of China

Cai BQ, Cai SX, Chen RC, Cui LY, Feng YL, Gu YT, Huang SG, Liu RY, Liu GN, Shi HZ, Shi Y, Song YL, Sun TY, Wang CZ, Wang JL, Wen FQ, Xiao W, Xu YJ, Yan XX, Yao WZ, Yu Q, Zhang J, Zheng JP, Liu J, Bai CX

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:381-395

Published Date: 25 April 2014

Readers of this article also read:

COPD exacerbation frequency and its association with health care resource utilization and costs

Dhamane AD, Moretz C, Zhou Y, Burslem K, Saverno K, Jain G, Renda A, Kaila S

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2609-2618

Published Date: 3 December 2015

US veterans and their unique issues: enhancing health care professional awareness

Olenick M, Flowers M, Diaz VJ

Advances in Medical Education and Practice 2015, 6:635-639

Published Date: 1 December 2015

Simvastatin enhances Rho/actin/cell rigidity pathway contributing to mesenchymal stem cells’ osteogenic differentiation

Tai IC, Wang YH, Chen CH, Chuang SC, Chang JK, Ho ML

International Journal of Nanomedicine 2015, 10:5881-5894

Published Date: 21 September 2015

Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia

Hoggatt J, Tate TA, Pelus LM

International Journal of Nanomedicine 2015, 10:2647-2652

Published Date: 1 April 2015

Development of a lauric acid/albumin hybrid iron oxide nanoparticle system with improved biocompatibility

Zaloga J, Janko C, Nowak J, Matuszak J, Knaup S, Eberbeck D, Tietze R, Unterweger H, Friedrich RP, Duerr S, Heimke-Brinck R, Baum E, Cicha I, Dörje F, Odenbach S, Lyer S, Lee G, Alexiou C

International Journal of Nanomedicine 2014, 9:4847-4866

Published Date: 20 October 2014

Nanotechnology-based drug delivery systems for treatment of oral cancer: a review

Calixto G, Bernegossi J, Fonseca-Santos B, Chorilli M

International Journal of Nanomedicine 2014, 9:3719-3735

Published Date: 8 August 2014

Hemorrhage in mouse tumors induced by dodecaborate cluster lipids intended for boron neutron capture therapy

Schaffran T, Jiang N, Bergmann M, Küstermann E, Süss R, Schubert R, Wagner FM, Awad D, Gabel D

International Journal of Nanomedicine 2014, 9:3583-3590

Published Date: 29 July 2014